Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 2

Sponsor Class

NETWORK 2

Study Type

Interventional 2

Sponsor

Conditions

Rhabdomyosarcoma 8Wilms Tumor 6Sarcoma 6Malignant mesenchymal tumor 4Rhabdomyosarcoma, Embryonal 2Kidney Neoplasms 2Hydatidiform Mole 2Stage I Mixed Cell Type Kidney Wilms Tumor 1Sarcoma, Ewing 1Rhabdomyosarcoma, Alveolar 1Pleuropulmonary blastoma 1Gestational Trophoblastic Disease 1Fibrosarcoma 1Choriocarcinoma 1Carcinoma, Renal Cell 1Beckwith-Wiedemann Syndrome 1

Interventions

merphos 2Methotrexate 2Dactinomycin 2Leucovorin 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Hydatidiform Mole × Dactinomycin × Clear all
NCT01535053 2022-08-12

Dactinomycin or Methotrexate in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia

GOG Foundation

Phase 3 Completed
57 enrolled 12 charts

Choriocarcinoma, Hydatidiform Mole

NCT00003702 2018-05-15

Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia

GOG Foundation

Phase 3 Completed
240 enrolled 9 charts

Hydatidiform Mole

Data powered by HemOnc (CC BY 4.0) Colophon âš¡